Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
21.82
+0.56 (2.63%)
At close: Aug 21, 2026, 4:00 PM EDT
22.10
+0.28 (1.28%)
After-hours: Aug 21, 2026, 7:41 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $4.23 billion as of August 21, 2026. Its market cap has decreased by -35.71% in one year.
Market Cap
4.23B
Enterprise Value
3.54B
1-Year Change
-35.71%
Ranking
Category
Stock Price
$21.82
ChartMarket Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $4.23B, a decrease of -11.66%. That is a compound annual growth rate of -1.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 4.23B | 5.30% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celcuity | 4.58B |
| Enliven Therapeutics | 4.38B |
| Veradermics | 4.30B |
| Relay Therapeutics | 4.26B |
| Tango Therapeutics | 4.03B |
| Denali Therapeutics | 3.98B |
| Viking Therapeutics | 3.95B |
| Arcus Biosciences | 3.86B |